Penumbra, Inc. PEN 深 沪
已收盘 03-27 16:00:00 美东时间
335.10
-1.320
-0.39%
华盛通- 最 高337.37
- 今 开337.37
- 成交量 55.96万股
- 最 低 334.80
- 昨 收 336.42
- 总市值 131.50亿
- 52周最高 362.41
- 市盈率 静 74.10
- 换手率 1.43%
- 52周最低 221.26
- 委 比 0.00%
- 总股本 3924.31万
- 历史最高 362.41
- 量 比 0.92
- 振 幅 0.76%
- 历史最低 35.315
- 每 手 1
- 风险率 36.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Boston Scientific Corp Stock (BSX) Moved Up by 3.66% on Mar 26: Key Drivers Unveiled
• Stifel reiterated a Buy rating with a $90.00 price target on Boston Scientific. • Analysts maintain positive ratings with price targets ranging from $92 to $120. • Acquisition of Penumbra for $14.5 billion is expected to boost cardiovascular portfolio.
03-26 19:15
8 Stocks to Buy as Merger-Mania Takes Over
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.
03-11 00:42
Penumbra CFO Maggie Yuen Disposes of Common Shares
Penumbra CFO Maggie Yuen Disposes of Common Shares Maggie Yuen, Chief Financial Officer of Penumbra Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generativ
03-05 08:32
Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement
• Boston Scientific faces recall of AXIOS Stent, triggering investigations. • $14.5 billion Penumbra acquisition adds debt and dilutes earnings. • Electrophysiology segment underperformed; sales guidance lowered.
03-03 17:15
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Evercore ISI Group Maintains Outperform on Penumbra, Raises Price Target to $360
Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and raises the price target from $340 to $360.
02-26 23:42
财报速睇 | Penumbra, Inc. 2025财年年度营收14.04亿美元，同比增长17.5%；归母净利润1.78亿美元，同比增长1168.1%
华盛资讯2月26日讯，Penumbra, Inc.公布2025财年年度业绩，公司年度营收14.04亿美元，同比增长17.5%，归母净利润1.78亿美元，同比增长1168.1%。
02-26 02:50
财报速睇 | Penumbra, Inc. 2025财年Q4营收3.85亿美元，同比增长22.1%；归母净利润0.47亿美元，同比增长40.6%
华盛资讯2月26日讯，Penumbra, Inc.公布2025财年Q4业绩，公司Q4营收3.85亿美元，同比增长22.1%，归母净利润0.47亿美元，同比增长40.6%。
02-26 02:17
Penumbra Q4 Earnings Assessment
The earnings results for Penumbra (NYSE:PEN) for Q4 were made public on Wednesd...
02-26 02:04
Penumbra Q4 Adj. EPS $1.18 Beats $1.11 Estimate, Sales $385.385M Beat $366.795M Estimate
Penumbra (NYSE:PEN) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.11 by 6.12 percent. This is a 38.82 percent increase over earnings of $0.85 per share from the same
02-26 02:03
